1 |
Riesco G, Gutierrez P, Garcia M, et al (2006). The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane. Endocr relat cancer, 13, 257-69.
DOI
ScienceOn
|
2 |
Ringel M, Anderson J, Souza S, et al (2001). Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Mod Pathol, 14, 289-96.
DOI
ScienceOn
|
3 |
Yu WB, Tao SY, Zhang NS (2012). Is level V dissection necessary for low-risk patients with papillary thyroid cancer metastasis in lateral neck levels II, III, and IV. Asian Pac J Cancer Prev, 13, 4619-22.
과학기술학회마을
DOI
|
4 |
Zaman MU, Fatima N, Padhy AK, et al (2013).Controversies about radioactive iodine-131 remnant ablation in low risk thyroid cancers: are we near a consensus? Asian Pac J Cancer Prev, 14, 6209-13.
과학기술학회마을
DOI
|
5 |
Adeniran A, Zhu Z, Gandhi M, et al (2006). Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol, 30, 216-22.
DOI
ScienceOn
|
6 |
Agac A, Kutun S, cetin A (2013). Are the characteristics of thyroid cancer different in young patients? J Pediatr Endocrinol Metab, 27,497-502.
|
7 |
Cooper D, Doherty G, Haugen B, et al (2009). Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-214.
|
8 |
Davies L, Welch H (2014). Current Thyroid Cancer Trends in the United States. JAMA Otolaryngol Head Neck Surg, 140, 317-22.
DOI
ScienceOn
|
9 |
Danese D, Gardini A, Farsetti A, et al (1997). Thyroid carcinoma in children and adolescents. Eur J Pediatr, 156, 190-4.
DOI
|
10 |
Degroot L, Kaplan E, McCormick M, et al (1990). Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab, 71, 414-24.
DOI
|
11 |
Faggiano A, Coulot J, Bellon N, et al (2004). Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue. J Nucl Med, 45, 232-7.
|
12 |
Farahati J, Reiners C, Demidchik E (1999). Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid? J Nucl Med, 40, 2125.
|
13 |
Frankenthaler R, Sellin R, Cangir A, et al (1990). Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am J Surg, 160, 341-3.
DOI
ScienceOn
|
14 |
Kim SS, Kim SJ, Kim IJ, et al (2012). Comparison of clinical outcomes in differentiated thyroid carcinoma between children and young adult patients. Clin Nucl Med, 37, 850-3.
DOI
|
15 |
Gulcelik M, Kuru B, Dincer H, et al (2012). Complications of completion versus total thyroidectomy. Asian Pac J Cancer Prev, 13, 5225-8.
과학기술학회마을
DOI
|
16 |
Handkiewicz-Junak D, Wloch J, Roskosz J, et al (2007). Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J Nucl Med, 48, 879-88.
DOI
|
17 |
Hovens G, Stokkel M, Kievit J, et al (2007). Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab, 92, 2610-5.
DOI
ScienceOn
|
18 |
Lazar L, Lebenthal Y, Steinmetz A, et al (2009). Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr, 154, 708-14.
DOI
|
19 |
Lima J, Trovisco V, Soares P, et al (2004). BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. J Clin Endocrinol Metab, 89, 4267-71.
DOI
ScienceOn
|
20 |
Mehta V, Nikiforov Y, Ferris R (2013). Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery. Head Neck. 35, 1499-506.
|
21 |
Miller R, L Young J, Novakovic B (1995). Childhood cancer. Cancer, 75, 395-405.
DOI
|
22 |
Patel A, Jhiang S, Dogra S, et al (2002). Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents. Pediatr Res, 52, 737-44.
DOI
|
23 |
Lupi C, Giannini R, Ugolini C, et al (2007). Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab, 92, 4085-90.
DOI
ScienceOn
|